Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Mar;87(3):319-30.
doi: 10.1016/j.contraception.2012.08.002. Epub 2012 Sep 17.

Contraception technology: past, present and future

Affiliations
Review

Contraception technology: past, present and future

Regine Sitruk-Ware et al. Contraception. 2013 Mar.

Abstract

Steady progress in contraception research has been achieved over the past 50 years. Hormonal and nonhormonal modern contraceptives have improved women's lives by reducing different health conditions that contributed to considerable morbidity. However, the contraceptives available today are not suitable to all users, and the need to expand contraceptive choices still exists. Novel products such as new implants, contraceptive vaginal rings, transdermal patches and newer combinations of oral contraceptives have recently been introduced in family planning programs, and hormonal contraception is widely used for spacing and limiting births. Concerns over the adverse effects of hormonal contraceptives have led to research and development of new combinations with improved metabolic profile. Recent developments include use of natural compounds such as estradiol and estradiol valerate with the hope to decrease thrombotic risk, in combination with newer progestins derived from the progesterone structure or from spirolactone, in order to avoid the androgenic effects. Progesterone antagonists and progesterone receptor modulators are highly effective in blocking ovulation and preventing follicular rupture and are undergoing investigations in the form of oral pills and in semi-long-acting delivery systems. Future developments also include the combination of a contraceptive with an antiretroviral agent for dual contraception and protection against sexually transmitted diseases, to be used before intercourse or on demand, as well as for continuous use in dual-protection rings. Although clinical trials of male contraception have reflected promising results, limited involvement of industry in that area of research has decreased the likelihood of having a male method available in the current decade. Development of nonhormonal methods is still at an early stage of research, with the identification of specific targets within the reproductive system in ovaries and testes, as well as interactions between spermatozoa and ova. It is hoped that the introduction of new methods with additional health benefits would help women and couples with unmet needs to obtain access to a wider range of contraceptives with improved acceptability.

PubMed Disclaimer

References

    1. Townsend JW, Sitruk-Ware R, Williams K, Askew I, Brill K. New strategies for providing hormonal contraception in developing countries. Contraception. 2011;83:405–409. - PubMed
    1. Giudice LC, Sitruk-Ware R, Bremner WJ, Hillard P. Eunice Kennedy Shriver National Institute of Child Health and Human Development. Bethesda, Maryland: 2011. Jan 25–26, Scientific Vision Workshop on Reproduction, Workshop White Paper. http://www.nichd.nih.gov/vision/comments/whitepapers/NICHD_Reproduction_....
    1. United Nations (UN) World Contraceptive Use 2007 [wall chart] New York: UN Department of Economic and Social Affairs, Population Division; 2008. Available at: www.un.org/esa/population/publications/contraceptive2007/contraceptive20....
    1. Population Reference Bureau Staff. Transitions in world population. Popul Bull. 2004:1–43.
    1. World Population Data Sheet of the Population Reference Bureau. Washington (DC): Population Reference Bureau; 2004. pp. 1–17.

Substances